Pulmonary Rehab Reaches 1.4% of Korean COPD Patients
According to a nationwide study, pulmonary rehab rates in South Korea gradually increased from 0.03% to 1.4% during a four-year period, but that number remains "suboptimal."
Tag: global health
All
Latest
All
Latest
WHO Launches E-course on Pediatric Tuberculosis Management
On World Children's Day (Nov 20), the World Health Organization launched a new e-course on the management of tuberculosis in children and adolescents.
All
Latest
Higher Socioeconomic Status Linked to Increased Air Pollution Exposure in China
People living in China who have a higher socioeconomic status are actually more exposed to outdoor air pollution, according to findings published in Environmental Health Perspectives.
Canada Authorizes Novavax COVID-19 Vaccine for Adults
Health Canada has granted authorization for Novavax Inc’s COVID-19 vaccine “Nuvaxovid” for adults age 18 and older.
Read More
COVID Mortality Disparities in the UK
The impact of the COVID-19 pandemic hit hardest in deprived areas of England and Wales, with excess years of life lost more than three times as high in the Northwest than the Southwest of England.
Read More
Novavax Vaccine Authorized in Great Britain, New Zealand
Novavax Inc has received authorizations for its COVID-19 vaccine NVX-CoV2373 (brand name Nuvaxovid) in Great Britain and in New Zealand, the company reports.
Read More
ViSi Mobile Continuous Patient Monitoring System Expands in EU
Sotera Wireless will bring its ViSi Mobile patient monitoring technology products to the Netherlands, Belgium, and Luxembourg.
Read More
First Ever World Bronchiectasis Day Scheduled for July 1
Global lung health organizations from the US, Europe, Australia, and Asia have established the first World Bronchiectasis Day for July 1, 2022, to raise awareness of bronchiectasis and its increased prevalence in many countries.
Read More
COVID-19 Lethality Increased in Late 2020
A new statistical analysis supports beliefs that COVID-19 became more lethal in the UK in late 2020, while also suggesting that multiple factors—not just the alpha variant of the virus that causes COVID-19—were to blame.
Read More
Traffic-related Pollution Causes 2 Million Pediatric Asthma Cases
Nearly 2 million new cases of pediatric asthma every year may be caused by a traffic-related air pollutant, a problem particularly important in big cities around the world.
Read More
J&J COVID-19 Vaccine 85% Effective against Hospitalizations
The Johnson & Johnson booster reduced the risk of hospitalization from COVID-19 among healthcare workers in South Africa after Omicron became the dominant variant
Read More
New Zealand Introduces Cigarette Ban
New Zealand is phasing out the sale of cigarettes, under a law expected to be enacted next year.
Read More
Merck VaxNeuvance Pneumococcal Vaccine Approved in EU
The European Commission approved Merck’s VaxNeuvance (Pneumococcal 15-valent Conjugate Vaccine) for prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years of age and older.
Read More
Merck to License COVID-19 Antiviral to Drugmakers in Other Companies
Merck has entered into a voluntary licensing agreement to allow the production of its investigational COVID-19 antiviral molnupiravir by drugmakers in 105 low- and middle-income countries.
Read More
Novavax Pursuing UK Authorization for COVID-19 Vaccine
Novavax has completed its rolling regulatory submission for authorization of its NVX-CoV2373 COVID-19 vaccine candidate in the United Kingdom.
Read More